» Articles » PMID: 26479846

Preparation and In vitro Evaluation of Methotrexate-loaded Magnetic Nanoparticles Modified with Biocompatible Copolymers

Overview
Date 2015 Oct 20
PMID 26479846
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Superparamagnetic iron oxide nanoparticles (SPION) are attractive materials that have been widely used in medicine for drug delivery, diagnostic imaging and therapeutic applications. In our study, SPION and the anticancer drug, Methotrexate, were encapsulated into polycaprolactone-polyethylene glycol (PCL-PEG) nanoparticles for local treatment. The magnetic properties conferred by SPION could help to maintain the nanoparticles in the joint with an external magnet. The drug encapsulation efficiency achieved for Fe3O4 magnetic nanoparticles modified with PCL-PEG copolymer was 92.36%. There is potential for use of these nanoparticles for biomedical application.

Citing Articles

ROS-Generating Poly(Ethylene Glycol)-Conjugated FeO Nanoparticles as Cancer-Targeting Sustained Release Carrier of Doxorubicin.

Adilakshmi B, Reddy O, Hemalatha D, Krishna Rao K, Lai W Int J Nanomedicine. 2022; 17:4989-5000.

PMID: 36275478 PMC: 9584772. DOI: 10.2147/IJN.S379200.


The synthesis, characterization and applications of poly[-isopropylacrylamide--3-allyloxy-1,2-propanediol] grafted onto modified magnetic nanoparticles.

Alipour A, Shekardasht M, Gharbani P RSC Adv. 2022; 10(6):3511-3519.

PMID: 35497763 PMC: 9048845. DOI: 10.1039/c9ra09105j.


Toxicity Assessment of PEG-PCCL Nanoparticles and Preliminary Investigation on Its Anti-tumor Effect of Paclitaxel-Loading.

Li W, Li W, Kuang Y, Yang T, Zhu J, Xu Z Nanoscale Res Lett. 2018; 13(1):253.

PMID: 30143890 PMC: 6108981. DOI: 10.1186/s11671-018-2615-1.


Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.

Arias L, Pessan J, Vieira A, Lima T, Delbem A, Monteiro D Antibiotics (Basel). 2018; 7(2).

PMID: 29890753 PMC: 6023022. DOI: 10.3390/antibiotics7020046.


Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.

Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y Pediatr Res. 2017; 82(3):527-535.

PMID: 28419087 PMC: 5766270. DOI: 10.1038/pr.2017.74.